Pediatrics
New Research on Oncology - Brain Cancer Reveals Promising Results
Researchers at the Department of Research and Development conducted a phase I nonrandomized clinical trial to assess the safety, feasibility, and potential efficacy of the intrathecal injection of multiple doses of allogenic NK cells in pediatric patients with refractory/recurrent gliomas. The study involved nine patients who received weekly doses